Hologic Reports 3 Percent Drop in Q1 Revenues | GenomeWeb

NEW YORK (GenomeWeb News) —Hologic reported after the close of the market on Monday that fiscal first-quarter revenues declined 3 percent year over year, although its molecular diagnostic product sales helped mitigate this decline.

For the three months ended Dec. 28, 2013, Hologic's revenues totaled $612.4 million compared to $631.4 million a year ago, but besting the consensus Wall Street estimate of $609.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.